Specific in vitro interaction between papillomavirus E2 proteins and TBP-associated factors

Intervirology

Volumn 47, Issue 6, 2004, Pages 342-349

  Carrillo, Elba ^a   Garrido, Efrain ^a   Gariglio, Patricio ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

BPV; E2; HPV; TAFs; Transcription

Indexed keywords

E2 PROTEIN; TATA BINDING PROTEIN ASSOCIATED FACTOR; TRANSCRIPTION FACTOR IID; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

ANIMALS; BOVINE PAPILLOMAVIRUS 1; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; PAPILLOMAVIRIDAE; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TATA-BOX BINDING PROTEIN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

BOVINAE; BOVINE PARVOVIRUS; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRUS;

EID: 9144251847     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080878     Document Type: Article

References (57)

1. zur Hausen H, de Villiers EM : Human papillomaviruses. Annu Rev Microbiol 1994;48:427-447.
2. zur Hausen H: Viruses in human cancers. Science 1991;254:1167-1173.
3. McBride AA, Romanczuk H, Howley PM: The papillomavirus E2 regulatory proteins. J Biol Chem 1991;266:18411-18414.
4. Androphy EJ, Lowy DR, Schiller JT: Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature 1987;325:70-73.
5. Hawley-Nelson P, Androphy EJ, Lowy DR, Schiller JT: The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer. EMBO J 1988;7:525-531.
6. Hirochika H, Hirochika R, Broker TR, Chow LT: Functional mapping of the human papillomavirus type 11 transcriptional enhancer and its interaction with the trans-acting E2 proteins. Genes Dev 1988;2:54-67.
7. Li R, Knight J, Ream G, Stenlund A, Botchan M: Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes Dev 1989;3:510-526.
8. Moskaluk C, Bastia D: The E2 'gene' of bovine papillomavirus encodes an enhancer-binding protein. Proc Natl Acad Sci USA 1987;84:1215-1218.
9. Guido M, Zamorano R, Garrido-Guerrero E, Gariglio P, García- Carrancá A: Early promoters of genital and cutaneous human papillomaviruses are differentially regulated by the bovine papillomavirus type 1 E2 gene product. J Gen Virol 1992;73:1395-1400.
10. Garrido-Guerrero E, Carrillo E, Guido M, Zamorano R, García- Carrancá A, Gariglio P: Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions. Arch Med Res 1996;27:389-394.
11. Stenlund A, Botchan MR: The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor. Genes Dev 1990;4:123-136.
12. Breiding DE, Sverdrup F, Grossel MJ, Moscufo N, Boonchai W, Androphy EJ: Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain. Mol Cell Biol 1997;17:7208-7219.
13. McBride AA, Schlegel R, Howley PM: The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity. EMBO J 1988;7:533-539.
14. Giri I, Yaniv M: Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains. EMBO J 1988;7:2823-2829.
15. McBride AA, Byrne JC, Howley PM: E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: Transactivation is mediated by the conserved amino-terminal domain. Proc Natl Acad Sci USA 1989;86:510-514.
16. Moskaluk C, Bastia D: The bovine papillomavirus type 1 transcriptional activator E2 protein binds to its DNA recognition sequence as a dimer. Virology 1989;169:236-238.
17. Rank NM, Lambert PF: Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB. J Virol 1995;69:6323-6334.
18. Benson JD, Lawande R, Howley PM: Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins. J Virol 1997;71:8041-8047.
19. Spalholz BA, Lambert PF, Yee CL, Howley PM: Bovine papillomavirus transcriptional regulation: Localization of the E2-responsive elements of the long control region. J Virol 1987;61:2128-2137.
20. Thierry F, Dostatni N, Arnos F, Yaniv M: Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance. Mol Cell Biol 1990;10:4431-4437.
21. Li R, Knight JD, Jackson SP, Tijan R, Botchan MR: Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription. Cell 1991;65:493-505.
22. Steger G, Ham J, Lefebvre O, Yaniv M: The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding. EMBO J 1995;14:329-340.
23. Enzenauer C, Mengus G, Lavigne A, Davidson I, Pfister H, May M: Interaction of human papillomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex. Intervirology 1998;41:80-90.
24. Dostatni N, Lambert PF, Sousa R, Ham J, Howley PM, Yaniv M: The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev 1991;5:1657-1671.
25. Demeret C, Yaniv M, Thierry F: The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter. J Virol 1994;68:7075-7082.
26. Goodwin EC, Naeger LK, Breiding DE, Androphy E, DiMaio D: Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines. J Virol 1998;72:3925-3934.
27. Nishimura A, Ono T, Ishimoto A, Dowhanick JJ, Frizzell MA, Howley PM, Sakai H: Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition. J Virol 2000;74:3752-3760.
28. Ptashne M, Gann A: Transcriptional activation by recruitment. Nature 1997;386:569-577.
29. Goodrich J, Tjian R: TBP-TAF complexes: Selectivity factors for eukaryotic transcription. Curr Opin Cell Biol 1994;6:403-409.
30. Tanese N, Pugh BF, Tjian R: Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex. Genes Dev 1991;5:2212-2224.
31. Reese JC, Apone L, Walker SS, Griffin LA, Green MR: Yeast TAFIIS in a multisubunit complex required for activated transcription. Nature 1994;371:523-527.
32. Sauer F, Wassarman D, Rubin G, Tjian R: TAF(II)s mediate activation of transcription in the Drosophila embryo. Cell 1996;87:1271-1284.
33. Michel B, Komarnitsky P, Buratowski S: Histone-like TAFs are essential for transcription in vivo. Mol Cell 1998;2:663-673.
34. Pugh B, Tjian R: Mechanism of transcriptional activation by Sp1: Evidence for coactivators. Cell 1990;61:1187-1197.
35. Verrijzer C, Chen J, Yokomori K, Tjian R: Binding of TAFs to core elements directs promoter selectivity by RNA polymerase II. Cell 1995;81:1115-1125.
36. Jacobson R, Ladurner AG, King DS, Tjian R: Structure and function of a human TAFII250 double bromodomain module. Science 2000;288:1422-1425.
37. Wassarman DA, Sauer F: TAF(II)250:A transcription toolbox. J Cell Sci 2001;114:2895-2902.
38. Hisatake K, Ohta T, Takada R, Guermah M, Horikoshi M, Nakatani Y, Roeder RG: Evolutionary conservation of human TATA-binding-polypeptide-associated factors TAFII31 and TAFII80 and interactions of TAFII80 with other TAFs and with general transcription factors. Proc Natl Acad Sci USA 1995;92:8195-8199.
39. Smith DB, Johnson KS: Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988;67:31-40.
40. Lai JS, Herr W: Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. Proc Natl Acad Sci USA 1992;89:6958-6962.
41. Hisatake K, Hasegawa S, Takada R, Nakatani Y, Horikoshi M, Roeder RG: The p250 subunit of native TATA box-binding factor TFIID is the cell-cycle regulatory protein CCG1. Nature 1993;362:179-181.
42. Sekiguchi T, Nakashima T, Hayashida T, Kuraoka A, Hashimoto S, Tsuchida N, Shibata Y, Hunter T, Nishimoto T: Apoptosis is induced in BHK cells by the tsBN462/13 mutation in the CCG1/TAFII250 subunit of the TFIID basal transcription factor. Exp Cell Res 1995;218:490-498.
43. Mizzen C, Yang X, Kokubo T, Brownell J, Bannister A, Owen-Hughes T, Workman J, Wang L, Berger S, Kouzarides T, Nakatani Y, Allis CD: The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell 1996;87:1261-1270.
44. Dikstein R, Ruppert S, Tjian R: TAFII250 is a bipartite protein kinase that phosphorylates the base transcription factor RAP74. Cell 1996;84:781-790.
45. O'Brien T, Tjian R: Functional analysis of the human TAFII250 N-terminal kinase domain. Mol Cell 1998;1:905-911.
46. Ruppert S, Wang E, Tjian R: Cloning and expression of human TAFII250:A TBP-associated factor implicated in cell-cycle regulation. Nature 1993;362:175-179.
47. Kokubo T, Yamashita S, Horikoshi M, Roeder RG, Nakatani Y: Interaction between the N-terminal domain of the 230-kDa subunit and the TATA box-binding subunit of TFIID negatively regulates TATA-box binding. Proc Natl Acad Sci USA 1994;91:3520-3524.
48. Ruppert S, Tjian R: Human TAFII250 interacts with RAP74:Implications for RNA polymerase II initiation. Genes Dev 1995;9:2747-2755.
49. Weissman JD, Hwang JR, Singer DS: Extensive interactions between HIV TAT and TAF(II)250. Biochim Biophys Acta 2001;1546:156-163.
50. Carrozza M, DeLuca NA: Interaction of the viral activator protein ICP4 with TFIID through TAF250. Mol Cell Biol 1996;16:3085-3093.
51. Thut CJ, Chen JL, Klemm R, Tjian R: p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science 1995;267:100-104.
52. Liu D, Ishima R, Tong K, Bagby S, Kokubo T, Muhandiram DR, Kay LE, Nakatani Y, Ikura M: Solution structure of a TBP-TAF(II)230 complex: Protein mimicry of the minor groove surface of the TATA box unwound by TBP. Cell 1998;94:573-583.
53. Lively TN, Ferguson HA, Galasinski SK, Seto AG, Goodrich JA: c-Jun binds the N terminus of human TAF(II)250 to derepress RNA polymerase II transcription in vitro. J Biol Chem 2001;276:25582-25588.
54. Kotani T, Banno K, Ikura M, Hinnebusch AG, Nakatani Y, Kawaichi M, Kokubo T: A role of transcriptional activators as antirepressors for the autoinhibitory activity of TATA box binding of transcription factor IID. Proc. Natl Acad Sci USA 2000;97:7178-7183.
55. Wu SY, Chiang CM: TATA-binding protein-associated factors enhance the recruitment of RNA polymerase II by transcriptional activators. J Biol Chem 2001;276:34235-34243.
56. Thierry F, Yaniv M: The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J 1987;11:3391-3397.
57. Steger G, Corbach S: Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol 1997;71:50-58.